# Clinical-Lab-Data-Analysis 

### Demographics 

## Table 1: Age 

| Category  | Drug Group Mean | Drug Group Std Dev | Control Group Mean | Control Group Std Dev |
|-----------|------------------|--------------------|--------------------|----------------------|
| Recipient | 41.94            | 10.62              | 36.70              | 11.42                |
| Donor     | 49.02            | 11.41              | 47.67              | 11.43                |

## Table 2: Relationship of Recipient with Donor

| Category  | Drug Group Records | Control Group Records |
|-----------|--------------------|-----------------------|
| Related   | 3                  | 6                     |
| Spousal   | 5                  | -                     |
| Unrelated | 2                  | 4                     |
| Total     | 10                 | 10                    |

## Table 3: Gender Analysis

| Category  | Drug Group N | Control Group N |
|-----------|--------------|-----------------|
| Recipient | 10           | 1 (female), 8 (male)  |
| Donor     | 10 (female)  | 6 (female), 3 (male)  |

### Insights: 

A. Age:

1. Drug Group: Recipients have an average age of 41.94 years (Std Dev: 10.62), while donors average 49.02 years (Std Dev: 11.41).
2. Control Group: Recipients are younger, averaging 36.70 years (Std Dev: 11.42), with donors at 47.67 years (Std Dev: 11.43).

B. Relationship with Donor:

1. Drug Group: Most donors are spousal (5), followed by related (3), and unrelated (2).
2. Control Group: More recipients are related to donors (6) compared to unrelated (4).

C. Gender Analysis:

1. Drug Group: All recipients are male (10) and all donors are female (10).
2. Control Group: Recipients are mostly male (8), with one female, while donors are predominantly female (6), with three males.

### Lab Data
### Table 1: Analysis of Serum Creatinine on Different Days 

| Day   | Drug Group N | Drug Group Mean | Drug Group Std | Drug Group Range | Control Group N | Control Group Mean | Control Group Std | Control Group Range |
|-------|--------------|-----------------|----------------|------------------|-----------------|--------------------|-------------------|---------------------|
| day3  | 10           | 1.87            | 1.54           | 5.30             | 9               | 1.83               | 0.59              | 1.90                |
| day7  | 10           | 1.53            | 0.73           | 2.60             | 9               | 1.64               | 0.41              | 1.30                |
| day15 | 8            | 1.58            | 0.52           | 1.80             | 9               | 1.68               | 0.62              | 2.00                |
| day30 | 7            | 1.62            | 0.18           | 0.50             | 8               | 1.46               | 0.39              | 1.10                |
| day90 | 3            | 1.60            | 0.10           | 0.20             | 4               | 1.43               | 0.15              | 0.30                |
| day180| 2            | 1.55            | 0.35           | 0.50             | 2               | 1.50               | 0.14              | 0.20                |
| day360| 2            | 1.50            | 0.14           | 0.20             | 0               | .                  | .                 | .                   |
| day720| 1            | 1.50            | .              | 0.00             | 0               | .                  | .                 | .                   |

### Table 2: Analysis of HB on Different Days

| Day   | Drug Group N | Drug Group Mean | Drug Group Std | Drug Group Range | Control Group N | Control Group Mean | Control Group Std | Control Group Range |
|-------|--------------|-----------------|----------------|------------------|-----------------|--------------------|-------------------|---------------------|
| day0  | 8            | 9.03            | 1.68           | 5.70             | 9               | 8.39               | 1.80              | 5.40                |
| day3  | 8            | 8.76            | 3.41           | 10.50            | 9               | 8.68               | 2.17              | 5.80                |
| day7  | 8            | 9.23            | 2.24           | 7.50             | 9               | 8.83               | 2.60              | 8.20                |
| day14 | 8            | 10.14           | 1.63           | 5.80             | 8               | 10.33              | 1.66              | 4.50                |
| day30 | 7            | 10.19           | 1.45           | 4.10             | 8               | 12.23              | 1.29              | 3.40                |
| day90 | 3            | 12.57           | 0.29           | 0.50             | 4               | 11.85              | 1.42              | 3.40                |
| day180| 2            | 12.55           | 1.34           | 1.90             | 2               | 14.10              | 0.28              | 0.40                |
| day360| 2            | 13.10           | 0.99           | 1.40             | 0               | .                  | .                 | .                   |
| day720| 0            | .               | .              | .                | 0               | .                  | .                 | .                   |

### Table 3: Analysis of Platelets on Different Days

| Day   | Drug Group N | Drug Group Mean | Drug Group Std | Drug Group Range | Control Group N | Control Group Mean | Control Group Std | Control Group Range |
|-------|--------------|-----------------|----------------|------------------|-----------------|--------------------|-------------------|---------------------|
| day0  | 4            | 221.50          | 62.96          | 132.00           | 9               | 225.7              | 54.04             | 166.8               |
| day3  | 4            | 166.75          | 36.37          | 84.00            | 9               | 197.9              | 34.58             | 157.7               |
| day7  | 6            | 227.67          | 134.36         | 397.00           | 9               | 9.23               | 2.24              | 7.50                |
| day14 | 3            | 318.33          | 112.45         | 204.00           | 8               | 10.14              | 1.63              | 5.80                |
| day30 | 2            | 168.00          | 32.53          | 46.00            | 7               | 10.19              | 1.45              | 4.10                |
| day90 | 1            | 190.00          | .              | 0.00             | 3               | 12.57              | 0.29              | 0.50                |
| day180| 0            | .               | .              | .                | 2               | 12.55              | 1.34              | 1.90                |
| day360| 2            | 226.00          | 155.56         | 220.00           | 2               | 13.10              | 0.99              | 1.40                |
| day720| 1            | 287.00          | .              | 0.00             | 0               | .                  | .                 | .                   |

### Table 4: Analysis of Urine Test

| Day   | Drug Group Records Observed | Control Group Records Observed |
|-------|-----------------------------|--------------------------------|
| day0  | 0                           | 0                              |
| day3  | 0                           | 1                              |
| day7  | 0                           | 1                              |
| day14 | 4                           | 4                              |
| day30 | 7                           | 5                              |
| day90 | 4                           | 2                              |
| day180| 2                           | 2                              |
| day360| 2                           | 0                              |
| day720| 0                           | 0                              |

### Table 5: Analysis of CD3 on Different Days

| Day   | Drug Group N | Drug Group Mean | Drug Group Std | Drug Group Range | Control Group N | Control Group Mean | Control Group Std | Control Group Range |
|-------|--------------|-----------------|----------------|------------------|-----------------|--------------------|-------------------|---------------------|
| day0  | 5            | 837.00          | 509.54         | 1137.00          | 2               | 198.50             | 72.83             | 103.00              |
| day3  | 7            | 42.29           | 55.94          | 122.00           | 1               | 298.00             | .                 | 0.00                |
| day7  | 2            | 543.50          | 218.50         | 309.00           | 0               | .                  | .                 | .                   |
| day14 | 0            | .               | .              | .                | 1               | 570.00             | .                 | 0.00                |
| day30 | 4            | 318.25          | 246.33         | 548.00           | 4               | 648.75             | 300.27            | 663.00              |
| day90 | 1            | 236.00          | .              | 0.00             | 5               | 943.80             | 644.86            | 1287.00             |
| day180| 1            | 523.00          | .              | 0.00             | 1               | 780.00             | .                 | 0.00                |
| day360| 0            | .               | .              | .                | 0               | .                  | .                 | .                   |
| day720| 1            | 1042.00         | .              | 0.00             | 0               | .                  | .                 | .                   |

### Table 6: Analysis of CD4 on Different Days

| Day   | Drug Group N | Drug Group Mean | Drug Group Std | Drug Group Range | Control Group N | Control Group Mean | Control Group Std | Control Group Range |
|-------|--------------|-----------------|----------------|------------------|-----------------|--------------------|-------------------|---------------------|
| day0  | 6            | 401.83          | 342.32         | 859.00           | 2               | 98.00              | 45.25             | 64.00               |
| day3  | 7            | 11.14           | 23.03          | 63.00            | 1               | 124.00             | .                 | 0.00                |
| day7  | 2            | 295.00          | 213.55         | 302.00           | 0               | .                  | .                 | .                   |
| day14 | 0            | .               | .              | .                | 1               | 157.00             | .                 | 0.00                |
| day30 | 4            | 107.25          | 109.54         | 257.00           | 4               | 246.50             | 140.71            | 330.00              |
| day90 | 1            | 176.00          | .              | 0.00             | 5               | 463.40             | 437.96            | 890.00              |
| day180| 1            | 306.00          | .              | 0.00             | 1               | 306.00             | .                 | 0.00                |
| day360| 0            | .               | .              |

#### Summary of lab data 
1. Serum Creatinine Analysis
Day 3: Drug group had a higher mean serum creatinine (1.87) than the control group (1.83).
Day 7: Both groups show a reduction in mean serum creatinine, but the control group shows a more significant reduction.
2. Hemoglobin (HB) Analysis
Day 14: Drug group's HB levels increased significantly from 9.23 to 10.14, while the control group's HB rose from 8.83 to 10.33.
Day 180: Control group showed a greater increase (14.10) compared to the drug group (12.55).
3. Platelet Count Analysis
Day 14: Drug group had a significantly higher mean platelet count (318.33) compared to the control group.
Day 360: The drug group maintained higher platelet counts (226.00) than the control group.
4. CD3 and CD4 Counts
CD3 Day 30: Control group showed higher mean CD3 levels (648.75) compared to the drug group (318.25).
CD4 Day 30: Control group also showed higher CD4 levels (246.50) compared to the drug group (107.25).
5. Viral Infections
Both groups reported two cases of viral infection.
